MDxHealth SA (MDXH) - Product Pipeline Analysis, 2023 Update

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $750	48 Pages	GlobalData	July, 2023	GBDT18100607

Best Price Guarantee
Price	from $750
Length	48 Pages
Publisher	GlobalData
Published Date	July, 2023
SKU	GBDT18100607

Middle East and Africa (MEA) Flat Glass Market Summary, Competitive Analysis and Forecast to 2027

Summary

Flat Glass in Middle East & Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

Flat glass is typically used for windows and other applications, including glass tables and doors. It is also known as plate glass and sheet glass. By end-use, the market is segmented into building & construction, automotive, and others. The scope of others segment includes electronics, solar PV, and furniture.
The Middle East & African flat glass market had total revenues of $4.9 billion in 2022, representing a compound annual growth rate (CAGR) of 5.1% between 2017 and 2022.
Market consumption volume increased with a CAGR of 5.2% between 2017 and 2022, to reach a total of 5.3 million Tons in 2022.
Middle East & Africa has a share of 4.5% in the global flat glass market. Flat glass is in higher demand as a result of the need for more residential and commercial properties, which is being driven by the growing middle class and urbanisation.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the flat glass market in Middle East & Africa
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the flat glass market in Middle East & Africa
Leading company profiles reveal details of key flat glass market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Middle East & Africa flat glass market with five year forecasts

Reasons to Buy

What was the size of the Middle East & Africa flat glass market by value in 2022?
What will be the size of the Middle East & Africa flat glass market in 2027?
What factors are affecting the strength of competition in the Middle East & Africa flat glass market?
How has the market performed over the last five years?
Who are the top competitors in Middle East & Africa's flat glass market?

MDxHealth SA Company Overview: MDxHealth SA Company Snapshot; MDxHealth SA Pipeline Products and Ongoing Clinical Trials Overview; MDxHealth SA – Pipeline Analysis Overview; Business Description; MDxHealth SA - Key Facts; MDxHealth SA - Major Products and Services; MDxHealth SA Pipeline Products by Development Stage; MDxHealth SA Pipeline Products Overview; (Epi)genetic Diagnostic Assay - Kidney Cancer; (Epi)genetic Diagnostic Assay - Kidney Cancer Product Overview; AS-MDx Test; AS-MDx Test Product Overview; Bladder ConfirmMDx; Bladder ConfirmMDx Product Overview; Bladder RecurMdx; Bladder RecurMdx Product Overview; ClinicalMDx - Cervical Cancer; ClinicalMDx - Cervical Cancer Product Overview; ConfirmMDx Lung Cancer Test; ConfirmMDx Lung Cancer Test Product Overview; Diagnostic Test - Urologic Cancer; Diagnostic Test - Urologic Cancer Product Overview; Epigenetic Biomarker Test - Prostate Cancer; Epigenetic Biomarker Test - Prostate Cancer Product Overview; InformMDx - Colon Cancer; InformMDx - Colon Cancer Product Overview; InformMDx - Prostate Cancer CLIA Test; InformMDx - Prostate Cancer CLIA Test Product Overview; InformMDx Prognostic Test - Prostate Cancer; InformMDx Prognostic Test - Prostate Cancer Product Overview; Liquid Biopsy Epigenetic Assay - Oral Cancer; Liquid Biopsy Epigenetic Assay - Oral Cancer Product Overview; Molecular Diagnostic Test - Bladder Cancer; Molecular Diagnostic Test - Bladder Cancer Product Overview; MonitorMDx - Prostate Cancer; MonitorMDx - Prostate Cancer Product Overview; PharmacoDx - Breast Cancer; PharmacoDx - Breast Cancer Product Overview; PharmacoDx - Lung Cancer; PharmacoDx - Lung Cancer Product Overview; PredictMDx - Colon Cancer; PredictMDx - Colon Cancer Product Overview; RecurMDx - Prostate Cancer; RecurMDx - Prostate Cancer Product Overview; MDxHealth SA - Key Competitors; MDxHealth SA - Key Employees; MDxHealth SA - Key Employee Biographies; MDxHealth SA - Locations And Subsidiaries; Head Office; Other Locations & Subsidiaries; Recent Developments; MDxHealth SA, Recent Developments; Feb 22, 2023: MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023; Aug 02, 2022: Mdxhealth Acquires Oncotype DX GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results; Aug 26, 2021: MDxHealth Reports Half Year 2021 Results; May 27, 2021: MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings; Apr 20, 2020: MDxHealth to receive $2.3 million “Paycheck Protection Program” loan under the U.S. CARES Act; Apr 09, 2020: MDxHealth provides Q1-2020 business update; Feb 26, 2020: MDxHealth reports financial year 2019 results and provides outlook for 2020; Nov 11, 2019: MDxHealth provides Q3-2019 business update; Aug 29, 2019: MDxHealth reports half year 2019 financial results and strategic update; Aug 26, 2019: MDxHealth announces favorable draft medicare coverage for the SelectMDx test; Appendix; Methodology; About GlobalData; Contact Us; Disclaimer
List of Tables: Table 1: MDxHealth SA Pipeline Products and Ongoing Clinical Trials Overview; Table 2: MDxHealth SA Pipeline Products by Equipment Type; Table 3: MDxHealth SA Pipeline Products by Indication; Table 4: MDxHealth SA, Key Facts; Table 5: MDxHealth SA, Major Products and Services; Table 6: MDxHealth SA Number of Pipeline Products by Development Stage; Table 7: MDxHealth SA Pipeline Products Summary by Development Stage; Table 8: (Epi)genetic Diagnostic Assay - Kidney Cancer - Product Status; Table 9: (Epi)genetic Diagnostic Assay - Kidney Cancer - Product Description; Table 10: AS-MDx Test - Product Status; Table 11: AS-MDx Test - Product Description; Table 12: Bladder ConfirmMDx - Product Status; Table 13: Bladder ConfirmMDx - Product Description; Table 14: Bladder RecurMdx - Product Status; Table 15: Bladder RecurMdx - Product Description; Table 16: ClinicalMDx - Cervical Cancer - Product Status; Table 17: ClinicalMDx - Cervical Cancer - Product Description; Table 18: ConfirmMDx Lung Cancer Test - Product Status; Table 19: ConfirmMDx Lung Cancer Test - Product Description; Table 20: Diagnostic Test - Urologic Cancer - Product Status; Table 21: Diagnostic Test - Urologic Cancer - Product Description; Table 22: Epigenetic Biomarker Test - Prostate Cancer - Product Status; Table 23: Epigenetic Biomarker Test - Prostate Cancer - Product Description; Table 24: InformMDx - Colon Cancer - Product Status; Table 25: InformMDx - Colon Cancer - Product Description; Table 26: InformMDx - Prostate Cancer CLIA Test - Product Status; Table 27: InformMDx - Prostate Cancer CLIA Test - Product Description; Table 28: InformMDx Prognostic Test - Prostate Cancer - Product Status; Table 29: InformMDx Prognostic Test - Prostate Cancer - Product Description; Table 30: Liquid Biopsy Epigenetic Assay - Oral Cancer - Product Status; Table 31: Liquid Biopsy Epigenetic Assay - Oral Cancer - Product Description; Table 32: Molecular Diagnostic Test - Bladder Cancer - Product Status; Table 33: Molecular Diagnostic Test - Bladder Cancer - Product Description; Table 34: MonitorMDx - Prostate Cancer - Product Status; Table 35: MonitorMDx - Prostate Cancer - Product Description; Table 36: PharmacoDx - Breast Cancer - Product Status; Table 37: PharmacoDx - Breast Cancer - Product Description; Table 38: PharmacoDx - Lung Cancer - Product Status; Table 39: PharmacoDx - Lung Cancer - Product Description; Table 40: PredictMDx - Colon Cancer - Product Status; Table 41: PredictMDx - Colon Cancer - Product Description; Table 42: RecurMDx - Prostate Cancer - Product Status; Table 43: RecurMDx - Prostate Cancer - Product Description; Table 44: MDxHealth SA, Key Employees; Table 45: MDxHealth SA, Key Employee Biographies; Table 46: MDxHealth SA, Subsidiaries; Table 47: Glossary
List of Figures: Figure 1: MDxHealth SA Pipeline Products by Equipment Type; Figure 2: MDxHealth SA Pipeline Products by Development Stage